REGN

Regeneron

$770.79

-13.49 (-1.72%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 27.02.2026
$869.96
(+12.87%)
Strong Buy: 2
Buy: 17
Hold: 8
Sell: 0
Strong Sell: 0
Description:
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors.
Exchange:
NASDAQ
Country:
USA
Sector:
HEALTHCARE
Industry:
BIOTECHNOLOGY
Address:
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, UNITED STATES, 10591-6707
Fiscal year end:
December
Market capitalization:
$82.9 Billion
EBITDA:
$4.25 Billion
PERatio:
18.9
EPS:
41.49
Dividend per share:
$3.52
Dividend yield:
0.46%
Beta:
0.413

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
+77%
How much will you get:
$1,775
Prices dates:
29-01-2016: $417.82 and 30-01-2026: $741.45